171 related articles for article (PubMed ID: 36160438)
1. Differential effects of ketoconazole, fluconazole, and itraconazole on the pharmacokinetics of pyrotinib
Wang L; Wu F; Xu J; Wang Y; Fei W; Jiang H; Geng P; Zhou Q; Wang S; Zheng Y; Deng H
Front Pharmacol; 2022; 13():962731. PubMed ID: 36160438
[TBL] [Abstract][Full Text] [Related]
2. Comparison of the inhibitory effect of ketoconazole, voriconazole, fluconazole, and itraconazole on the pharmacokinetics of bosentan and its corresponding active metabolite hydroxy bosentan in rats.
Chen M; Zhang X; Chen Y; Sun W; Wang Z; Huang C; Hu G; Chen R
Xenobiotica; 2020 Mar; 50(3):280-287. PubMed ID: 31199171
[TBL] [Abstract][Full Text] [Related]
3. Comparative effects of the antimycotic drugs ketoconazole, fluconazole, itraconazole and terbinafine on the metabolism of cyclosporin by human liver microsomes.
Back DJ; Tjia JF
Br J Clin Pharmacol; 1991 Nov; 32(5):624-6. PubMed ID: 1659439
[TBL] [Abstract][Full Text] [Related]
4. Kinetic and dynamic interaction study of zolpidem with ketoconazole, itraconazole, and fluconazole.
Greenblatt DJ; von Moltke LL; Harmatz JS; Mertzanis P; Graf JA; Durol AL; Counihan M; Roth-Schechter B; Shader RI
Clin Pharmacol Ther; 1998 Dec; 64(6):661-71. PubMed ID: 9871431
[TBL] [Abstract][Full Text] [Related]
5. Azoles, allylamines and drug metabolism.
Back DJ; Tjia JF; Abel SM
Br J Dermatol; 1992 Feb; 126 Suppl 39():14-8. PubMed ID: 1311943
[TBL] [Abstract][Full Text] [Related]
6. Effects of ketoconazole, voriconazole, and itraconazole on the pharmacokinetics of apatinib in rats.
Lou D; Cui X; Bao SS; Sun W; Pan WH; Chen MC; Dong YY; Hu GX; Chen RJ; Wang Z
Drug Dev Ind Pharm; 2019 Apr; 45(4):689-693. PubMed ID: 30632818
[TBL] [Abstract][Full Text] [Related]
7. The Influence of Different Triazole Antifungal Agents on the Pharmacokinetics of Cyclophosphamide.
Cai T; Liao Y; Chen Z; Zhu Y; Qiu X
Ann Pharmacother; 2020 Jul; 54(7):676-683. PubMed ID: 31893943
[No Abstract] [Full Text] [Related]
8. [Drug-drug interaction of antifungal drugs].
Niwa T; Shiraga T; Takagi A
Yakugaku Zasshi; 2005 Oct; 125(10):795-805. PubMed ID: 16205037
[TBL] [Abstract][Full Text] [Related]
9. Origin of differences in susceptibility of Candida krusei to azole antifungal agents.
Marichal P; Gorrens J; Coene MC; Le Jeune L; Vanden Bossche H
Mycoses; 1995; 38(3-4):111-7. PubMed ID: 7477085
[TBL] [Abstract][Full Text] [Related]
10. The impact of azole antifungal drugs on imatinib metabolism in human liver microsomes.
Luo X; Li T; Yu Z; Xue X; Zhao H; Li N; Ma L; Yang C; Huang L; Feng W
Xenobiotica; 2019 Jul; 49(7):753-761. PubMed ID: 29770723
[TBL] [Abstract][Full Text] [Related]
11. Differential Impacts of Azole Antifungal Drugs on the Pharmacokinetic Profiles of Dasatinib in Rats by LC-MS-MS.
Luo X; Xue X; Li T; Zhang Y; Huang L; Cheng G
Curr Drug Metab; 2020; 21(13):1022-1030. PubMed ID: 33092505
[TBL] [Abstract][Full Text] [Related]
12. Differential effects of ketoconazole, itraconazole and voriconazole on the pharmacokinetics of imatinib and its main metabolite GCP74588 in rat.
Lin G; Wang C; Qiu X; Wang Z; Han A; Xu T; Kan X; Hu G
Drug Dev Ind Pharm; 2014 Dec; 40(12):1616-22. PubMed ID: 24053419
[TBL] [Abstract][Full Text] [Related]
13. Clinically significant azole cross-resistance in Candida isolates from HIV-positive patients with oral candidosis.
Cartledge JD; Midgley J; Gazzard BG
AIDS; 1997 Dec; 11(15):1839-44. PubMed ID: 9412702
[TBL] [Abstract][Full Text] [Related]
14. UPLC-MS/MS Measurement of the Effect of Isavuconazole, Itraconazole and Fluconazole on the Pharmacokinetics of Selinexor in Rats.
Li SL; Zhang Y; Cheng QS; Xin JZ; Dong ZQ; Qiu XJ
Infect Drug Resist; 2020; 13():3153-3161. PubMed ID: 32982330
[TBL] [Abstract][Full Text] [Related]
15. Comparison of two azole antifungal drugs, ketoconazole, and fluconazole, as modifiers of rat hepatic monooxygenase activity.
Houston JB; Humphrey MJ; Matthew DE; Tarbit MH
Biochem Pharmacol; 1988 Feb; 37(3):401-8. PubMed ID: 2827686
[TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetic optimisation of oral antifungal therapy.
Schäfer-Korting M
Clin Pharmacokinet; 1993 Oct; 25(4):329-41. PubMed ID: 8261715
[TBL] [Abstract][Full Text] [Related]
17. The classic azole antifungal drugs are highly potent endocrine disruptors in vitro inhibiting steroidogenic CYP enzymes at concentrations lower than therapeutic Cmax.
Munkboel CH; Rasmussen TB; Elgaard C; Olesen MK; Kretschmann AC; Styrishave B
Toxicology; 2019 Sep; 425():152247. PubMed ID: 31330226
[TBL] [Abstract][Full Text] [Related]
18. Drug interactions between nine antifungal agents and drugs metabolized by human cytochromes P450.
Niwa T; Imagawa Y; Yamazaki H
Curr Drug Metab; 2014; 15(7):651-79. PubMed ID: 25429674
[TBL] [Abstract][Full Text] [Related]
19. Effects of the antifungal agents on oxidative drug metabolism: clinical relevance.
Venkatakrishnan K; von Moltke LL; Greenblatt DJ
Clin Pharmacokinet; 2000 Feb; 38(2):111-80. PubMed ID: 10709776
[TBL] [Abstract][Full Text] [Related]
20. Inhibition and interaction of cytochrome P450 of Candida krusei with azole antifungal drugs.
Venkateswarlu K; Denning DW; Kelly SL
J Med Vet Mycol; 1997; 35(1):19-25. PubMed ID: 9061581
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
